• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难溶性药物α-戊基-3-(2-喹啉甲氧基)苯甲醇的处方前研究:剂型设计中碱的选择

Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.

作者信息

Serajuddin A T, Sheen P C, Mufson D, Bernstein D F, Augustine M A

出版信息

J Pharm Sci. 1986 May;75(5):492-6. doi: 10.1002/jps.2600750514.

DOI:10.1002/jps.2600750514
PMID:3735089
Abstract

The physicochemical properties of the base and hydrochloride salt of the poorly water-soluble drug alpha-pentyl-3-(2-quinolinylmethoxy) benzenemethanol (REV 5901) were investigated in order to select an appropriate form of the drug for dosage form development. The pH-solubility profiles of both the base and the salt at 37 degrees C were identical and were in agreement with a pKa value of 3.67 determined by the UV spectral method. The solubility of the drug (approximately 0.002 mg/mL at pH 6) increased gradually with a decrease in pH and reached a value of 0.95 mg/mL at pH 1; at pH values less than 1, the solubility decreased due to the common-ion effect. The pHmax, i.e., the pH of maximum solubility of the drug was, therefore, 1.0. The role of the pHmax in the selection of a salt or base form of a compound was investigated. Due to the conversion of the salt to the base at the surface of the dissolving solid at pH values greater than pHmax, the dissolution rates of both the base and the salt were identical. In the solid state, the salt existed in anhydrous and monohydrate forms; the anhydrous salt converted to the hydrate at greater than 40% relative humidity, and the hydrate lost water at 40-60 degrees C. The thermal properties of the salt were indicative of its potential instability, which was confirmed by accelerated stability studies. The base existed in a stable crystalline solid form, and also in an oily liquid form which converted to crystals on standing.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了选择适合剂型开发的药物形式,对难溶性药物α-戊基-3-(2-喹啉甲氧基)苯甲醇(REV 5901)的碱和盐酸盐的理化性质进行了研究。碱和盐在37℃时的pH-溶解度曲线相同,且与通过紫外光谱法测定的pKa值3.67一致。药物的溶解度(在pH 6时约为0.002 mg/mL)随着pH值的降低而逐渐增加,在pH 1时达到0.95 mg/mL;在pH值小于1时,由于同离子效应溶解度降低。因此,pHmax即药物最大溶解度时的pH值为1.0。研究了pHmax在选择化合物的盐或碱形式中的作用。由于在pH值大于pHmax时盐在溶解固体表面转化为碱,碱和盐的溶解速率相同。在固态下,盐以无水和一水合物形式存在;无水盐在相对湿度大于40%时转化为水合物,水合物在40-60℃时失水。盐的热性质表明其潜在的不稳定性,加速稳定性研究证实了这一点。碱以稳定的结晶固体形式存在,也以油状液体形式存在,静置时会转化为晶体。(摘要截断于250字)

相似文献

1
Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.难溶性药物α-戊基-3-(2-喹啉甲氧基)苯甲醇的处方前研究:剂型设计中碱的选择
J Pharm Sci. 1986 May;75(5):492-6. doi: 10.1002/jps.2600750514.
2
Disproportionation of Pharmaceutical Salts: pH and Phase-Solubility/pH Variance.药物盐的歧化作用:pH 值和相溶解度/pH 值变化。
Mol Pharm. 2021 Jul 5;18(7):2724-2743. doi: 10.1021/acs.molpharmaceut.1c00258. Epub 2021 Jun 18.
3
Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH and the In-silico Prediction of pH.盐溶解度和歧化反应 - 方程在 pH 值中的应用和局限性以及 pH 值的计算机预测。
J Pharm Sci. 2022 Jan;111(1):225-246. doi: 10.1016/j.xphs.2021.11.017. Epub 2021 Dec 1.
4
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
5
The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitions.所选候选药物的结晶盐形式表现出光、热和湿度诱导的多晶型转变。
Eur J Pharm Sci. 2019 Feb 1;128:128-136. doi: 10.1016/j.ejps.2018.11.028. Epub 2018 Nov 29.
6
Salt formation improved the properties of a candidate drug during early formulation development.成盐改善了候选药物在早期制剂开发过程中的性质。
Eur J Pharm Sci. 2018 Jul 30;120:162-171. doi: 10.1016/j.ejps.2018.04.048. Epub 2018 May 3.
7
Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.研究游离碱和两种不同盐形式的溶解度及溶出度随pH的变化情况。
Pharm Res. 2005 Apr;22(4):628-35. doi: 10.1007/s11095-005-2504-z. Epub 2005 Apr 7.
8
Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions.口服有机溶液后难溶性药物生物利用度增加的物理化学基础。
J Pharm Sci. 1988 Apr;77(4):325-9. doi: 10.1002/jps.2600770409.
9
Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions.
J Pharm Sci. 1988 May;77(5):414-7. doi: 10.1002/jps.2600770512.
10
Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.一种处于研发阶段的药物化合物的结晶柠檬酸盐的歧化反应:利用pH监测和在线拉曼光谱法表征动力学,以及使用傅里叶变换拉曼光谱(FT-Raman)、X射线粉末衍射(XRPD)和差示扫描量热法(DSC)对二元物理混合物中的结晶游离碱形式进行定量分析。
J Pharm Biomed Anal. 2014 Mar;90:186-91. doi: 10.1016/j.jpba.2013.12.001. Epub 2013 Dec 10.

引用本文的文献

1
Machine-Vision-Enabled Salt Dissolution Analysis.机器视觉辅助盐溶解分析。
Anal Chem. 2020 Jul 21;92(14):9730-9738. doi: 10.1021/acs.analchem.0c01068. Epub 2020 Jun 30.
2
Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810.微环境 pH 值调节对弱酸盐溶出速率和口服吸收的影响——以 GDC-0810 为例。
Pharm Res. 2018 Jan 29;35(2):37. doi: 10.1007/s11095-018-2347-z.